Close Asset Management’s Johnson & Johnson JNJ Stock Holding History

Close Asset Management’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.3M	Sell	50,148 -3,813	-7%	-$888K	0.33%	42
2025 Q4	$11.2M	Sell	53,961 -9,858	-15%	-$1.95M	0.25%	46
2025 Q3	$11.8M	Sell	63,819 -27,299	-30%	-$4.68M	0.26%	44
2025 Q2	$13.9M	Sell	91,118 -2,775	-3%	-$427K	0.41%	39
2025 Q1	$15.6M	Sell	93,893 -1,321	-1%	-$207K	0.45%	37
2024 Q4	$13.8M	Hold	95,214	–	–	0.39%	36
2024 Q3	$15.4M	Sell	95,214 -2,284	-2%	-$364K	0.47%	34
2024 Q2	$14.2M	Buy	97,498 +3,822	+4%	+$568K	0.48%	33
2024 Q1	$14.8M	Buy	93,676 +3,005	+3%	+$478K	0.54%	34
2023 Q4	$14.2M	Buy	90,671 +4,474	+5%	+$686K	0.59%	31
2023 Q3	$13.4M	Buy	86,197 +4,372	+5%	+$721K	0.69%	30
2023 Q2	$13.5M	Buy	81,825 +4,472	+6%	+$722K	0.63%	31
2023 Q1	$12M	Buy	77,353 +4,794	+7%	+$774K	0.59%	32
2022 Q4	$12.8M	Buy	72,559 +3,459	+5%	+$597K	0.68%	27
2022 Q3	$11.3M	Buy	69,100 +2,065	+3%	+$349K	0.64%	28
2022 Q2	$11.9M	Buy	67,035 +2,388	+4%	+$425K	0.56%	33
2022 Q1	$11.1M	Hold	64,647	–	–	0.39%	30
2021 Q4	$11.1M	Sell	64,647 -3,111	-5%	-$509K	0.39%	30
2021 Q3	$10.9M	Buy	67,758 +1,081	+2%	+$184K	0.53%	26
2021 Q2	$11M	Sell	66,677 -2,110	-3%	-$349K	0.53%	28
2021 Q1	$11.3M	Sell	68,787 -1,130	-2%	-$183K	0.6%	26
2020 Q4	$11M	Buy	69,917 +2,039	+3%	+$301K	0.83%	21
2020 Q3	$10.1M	Buy	67,878 +174	+0.3%	+$25.7K	0.69%	20
2020 Q2	$9.51M	Sell	67,704 -12,133	-15%	-$1.77M	0.71%	17
2020 Q1	$10.5M	Sell	79,837 -33	-0%	-$4.68K	0.93%	15
2019 Q4	$11.6M	Sell	79,870 -653	-0.8%	-$88.6K	0.91%	18
2019 Q3	$10.4M	Sell	80,523 -660,496	-89%	-$87M	0.92%	19
2019 Q2	$103M	Buy	741,019 +104,411	+16%	+$14.5M	8.02%	6
2019 Q1	$89M	Buy	636,608 +630,193	+9,824%	+$84.4M	7.57%	7
2018 Q4	$540K	Sell	6,415 -611,143	-99%	-$85.2M	0.06%	64
2018 Q3	$83.7M	Buy	617,558 +248,658	+67%	+$33M	6.75%	5
2018 Q2	$45.9M	Hold	368,900	–	–	3.9%	10
2018 Q1	$45.9M	Buy	368,900 +22,639	+7%	+$3.06M	3.72%	11
2017 Q4	$48.4M	Buy	346,261 +65,774	+23%	+$9.16M	4.37%	9
2017 Q3	$36.5M	Buy	280,487 +225,911	+414%	+$29.9M	3.61%	15
2017 Q2	$7.22M	Sell	54,576 -304	-0.6%	-$38.8K	0.81%	31
2017 Q1	$6.83M	Buy	54,880 +33,579	+158%	+$4.01M	0.72%	31
2016 Q4	$2.46M	Buy	+21,301	New	+$2.46M	0.37%	33

Other funds holding JNJ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Close Asset Management's JNJ Position: Q1 2026 in Review

Close Asset Management reduced its Johnson & Johnson (JNJ) stake by 7.1% in Q1 2026, selling an estimated $888K and leaving 50,148 shares worth $12.3M. The position accounts for 0.33% of the portfolio, ranked #42.

Close Asset Management first reported a position in JNJ in Q4 2016 and has held it in 38 quarters since. The position peaked at $103M in Q2 2019. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

Close Asset Management held 50,148 shares of Johnson & Johnson worth $12.3M as of Q1 2026.
Close Asset Management sold 3,813 Johnson & Johnson shares in Q1 2026, an estimated $888K.
Johnson & Johnson made up 0.33% of Close Asset Management's portfolio in Q1 2026, its #42 holding.
Close Asset Management first reported a position in Johnson & Johnson in Q4 2016 and has held it in 38 quarters since.
Close Asset Management's Johnson & Johnson position peaked at $103M in Q2 2019.
4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Close Asset Management's 13F filing for Q1 2026, filed 12 May 2026.